<?xml version='1.0' encoding='utf-8'?>
<document id="29096573"><sentence text="Drug-related problems and changes in drug utilization after medication reviews in nursing homes in Oslo, Norway." /><sentence text="We describe the drug-related problems (DRPs) identified during medication reviews (MRs) and the changes in drug utilization after MRs at nursing homes in Oslo, Norway" /><sentence text=" We explored predictors for the observed changes" /><sentence text="" /><sentence text="Observational before-after study" /><sentence text="" /><sentence text="Forty-one nursing homes" /><sentence text="" /><sentence text="MRs performed by multidisciplinary teams during November 2011 to February 2014" /><sentence text="" /><sentence text="In all, 2465 long-term care patients" /><sentence text="" /><sentence text="DRPs identified by explicit criteria (STOPP/START and NORGEP) and drug-drug interaction database; interventions to resolve DRPs; drug use changes after MR" /><sentence text="" /><sentence text="A total of 6158 DRPs were identified, an average of 2" /><sentence text="6 DRPs/patient, 2" /><sentence text="0 for regular and 0" /><sentence text="6 for pro re nata (prn) drugs" /><sentence text=" Of these patients, 17" /><sentence text="3% had no DRPs" /><sentence text=" The remaining 82" /><sentence text="7% of the patients had on average 3" /><sentence text="0 DRPs/patient" /><sentence text=" Use of unnecessary drugs (43" /><sentence text="5%), excess dosing (12" /><sentence text="5%) and lack of monitoring of the drug use (11%) were the most frequent DRPs" /><sentence text=" Opioids and psychotropic drugs were involved in 34" /><sentence text="4% of all DRPs" /><sentence text=" The mean number of drugs decreased after the MR from 6" /><sentence text="8 to 6" /><sentence text="3 for regular drugs and from 3" /><sentence text="0 to 2" /><sentence text="6 for prn drugs" /><sentence text=" Patients with DRPs experienced a decrease of 1" /><sentence text="1 drugs after MR (0" /><sentence text="5 for regular and 0" /><sentence text="6 for prn drugs)" /><sentence text=" The reduction was most pronounced for the regular use of antipsychotics, antidepressants, hypnotics/sedatives, diuretics, antithrombotic agents, antacid drugs; and for prn use of anxiolytics, opioids, hypnotics/sedatives, metoclopramide and NSAIDs"><entity charOffset="223-237" id="DDI-PubMed.29096573.s38.e0" text="metoclopramide" /></sentence><sentence text="" /><sentence text="The medication review resulted in less drug use, especially opioids and psychotropic drugs" /><sentence text="" /></document>